Alison Petrovich, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13963 Morse St, Cedar Lake, IN 46303 Phone: 219-374-5555 |
News Archive
Tarsa Therapeutics, Inc. today announced completion of its global Phase III ORACAL trial testing the company's once-daily oral recombinant calcitonin for the treatment of postmenopausal osteoporosis. Results from the ORACAL trial are expected in early spring. In addition, Tarsa announced initiation of a new Phase II study of its oral calcitonin for the prevention of postmenopausal osteoporosis.
As teens head back to school, health teachers may want to revise their lesson plans. Temple researchers have found that kids who engage in heavy drinking will more than likely also engage in heavy smoking, and they say educators can help combat the trend by addressing both topics as one health risk.
Ebstein's anomaly is a rare congenital valvular heart disease. Now, in patients with this disease, researchers of the Academic Medical Center Amsterdam in the Netherlands, the University of Newcastle, UK and the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch have identified mutations in a gene which plays an important role in the structure of the heart.
A new study reveals how dengue virus manages to reproduce itself in an infected person without triggering the body's normal defenses. Duke researchers report that dengue pulls off this hoax by co-opting a specialized structure within host cells for its own purposes, like a lazy roommate sneaking bits of his laundry into the communal wash.
› Verified 3 days ago